|
Volcano Corporation
Announces Litigation Status
|
 |
OCT Image |
|
February 5, 2010 -- San
Diego -- Volcano Corporation (Nasdaq: VOLC) today announced that the
jury
in the
litigation filed by Lightlab Imaging, Inc. on January 7, 2009
in the Superior Court of Massachusetts, Suffolk County reached
a verdict against Volcano and its wholly owned subsidiary, Axsun
Technologies. In December 2008, Volcano acquired Axsun, which
had an agreement to supply tunable lasers to Lightlab for use
in Lightlab's OCT (Optical Coherence Technology) imaging products
until April 2016, with exclusivity in the field of coronary artery
imaging expiring in April 2014. |
Since the acquisition, Axsun has continued
to supply lasers to Lightlab. The jury findings included that the
contract
specification for the laser Axsun supplies to Lightlab is a trade
secret of Lightlab, that Axsun agreed not to sell any tunable lasers
for use
in cardiology imaging to any third party during the exclusivity
period in the
contract, and that Axsun breached its contract with Lightlab. The jury further
found that Volcano intentionally interfered with Lightlab's advantageous
business relationship with Axsun. The jury was not charged with
determining damages, which, if any, would be established in a second
jury trial.
Volcano intends to appeal the jury verdict and is not in the position to estimate the possible loss attributable to this verdict. Volcano does not believe that this development will have a material impact on Volcano's OCT program or Axsun's business.
Volcano Corporation offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use digital and rotational IVUS imaging catheters, and advanced functionality options, such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) systems and catheters. Currently, more than 4,700 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming
from outside the United States. Volcano's wholly-owned subsidiary, Axsun Technologies, develops and manufactures optical monitors, lasers and optical engines used in telecommunications, spectroscopy and other industrial applications. For more information, visit the company's website at www.volcanocorp.com.
This news release contains forward-looking
statements within the meaning of the U.S. Private Securities Litigation
Reform Act of 1995. Any statements in this news release regarding
the LightLab litigation that are not historical facts may be considered "forward-looking statements," including
statements relating to the impact of the LightLab litigation. Forward-looking
statements are subject to risks and uncertainties, which may cause
Volcano's results to differ materially and adversely from the statements
contained herein. Some of the potential risks and uncertainties
that could cause actual results to differ from the results predicted
are detailed in the company's annual report on Form 10-K, quarterly
reports on Form 10-Q and other filings made with the Securities
and Exchange Commission. Undue reliance should not be placed on
forward-looking statements, which speak only as of the date they
are made. Volcano undertakes no obligation to update any forward-looking
statements to reflect new information, events or circumstances
after the date they were made, or to reflect the occurrence of
unanticipated events.
Source: Volcano
Corporation
|
